Thus, whether enhanced visfatin/Nampt levels is a deleterious factor promoting endothelial dysfunction in placenta and leading to preeclampsia or, if on the contrary, is a beneficial factor preventing apoptosis under inflammatory conditions and promoting angiogenesis in the placenta, or if it is just a biomarker, is still an open question [62]. This evidence concerns the gene NAMPT and endothelial dysfunction.